An entity of Swedish private equity firm EQT has agreed to acquire Qiagen for €10.8 billion (about $12.1 billion) cash, both ...

The University of Washington School of Medicine Institute for Protein Design (IPD) has partnered with Nvidia to develop an ...

The partnership is now expanding into a joint drug-target discovery effort that leverages proprietary causal biological data from PerturbAI.

ASHG President Susan Slaugenhaupt, PhD, opened the society’s Montreal meeting with a heartfelt address of hope, leadership, ...

Roche and Hansoh Pharmaceutical Group have launched their second collaboration focused on developing cancer-fighting antibody ...

The companies plan to first optimize Takara's SMART-seq RNA-seq library prep workflows on SPT Labtech's firefly liquid ...

IMU Biosciences and UK Biobank will profile 80,000 blood samples using technologies from Waters and Ultima Genomics.

Gene therapy firms need to consider patients when choosing a viral vector production method, say researchers behind new economic analysis.

Pluristyx leaders outline how better starting materials, automation, and process control can scale iPSC manufacturing.

PacBio and Verily Health will integrate HiFi long-read sequencing with health data and cloud tools to support biomedical ...

Catalytic reactive-hydrogen membranes capture and break down six PFAS in water, achieving up to 96% removal and 83% ...

A small-molecule therapy, VG-3927, targeting microglial TREM2 signaling showed neuroprotective effects in preclinical studies ...